At a glance
ClinicalIndex Comparison RecordN/ACompleted· 152 enrolled
Drug / intervention
Motivational Text Messages +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Randomized Trial of an Automated Smoking Cessation Intervention Via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary Care
In Brief
A clinical study evaluating Motivational Text Messages and Control for Nicotine Dependence, Cigarettes. Completed, enrolled 152 participants across 1 site.
Detailed Summary
This study is evaluating the feasibility and short term smoking cessation outcomes of an automated smoking cessation intervention delivered via mobile phone text messaging as an adjunct to Varenicline in a primary care setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence, Cigarettes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedFeb 2015
Primary CompletionOct 2015
TodayJul 2026
First PostedFeb 20, 2015
Enrollment StartJan 1, 2015
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.4 years ago
Interventions
Motivational Text Messagesbehavioral
Usual care plus motivational text messages sent via Mobile Phone. All participants receive the active medication, Varenicline.
Controlbehavioral
Usual Care. All participants receive the active medication, Varenicline.